Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$56,386,499
-$21,327,493 QoQ
Shares Held
827,631
-19.1% QoQ
Ownership
0.998%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.72004431926788.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2799556807321137.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Jun 30, 2020CallValue
$1,395,350
CallShares
27,500
PutValue
$1,395,350
PutShares
27,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. PTCT ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in PTCT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,386,499 | 827,631 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $77,713,992 | 1,023,091 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $53,785,219 | 876,409 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $37,887,776 | 775,753 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,711,807 | 602,665 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $34,515,172 | 764,625 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $30,512,560 | 822,441 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,193,794 | 791,164 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,963,809 | 480,021 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,510,174 | 526,494 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $7,616,844 | 339,886 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $17,334,855 | 426,232 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $21,927,915 | 452,682 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $20,345,907 | 533,034 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $25,374,995 | 505,478 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $19,876,970 | 496,180 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $8,521,865 | 228,407 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,003,672 | 527,333 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $8,492,028 | 228,219 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $11,383,902 | 269,314 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $24,342,776 | 514,103 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,141,496 | 706,890 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,000,199 | 385,031 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,395,350 | 27,500 | Put | Defined | 2020-08-12 | |
| 2020-06-30 | $43,679,275 | 860,845 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $1,395,350 | 27,500 | Call | Defined | 2020-08-12 | |
| 2020-03-31 | $26,843,843 | 601,745 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||